drugset / Trial / NCT02710071

Treatment of OSA Associated Hypertension With Nebivolol or Hydrochlorothiazide

NCT02710071

Phase 4 Completed 41 enrolled University of California, San Diego
RandomizedCrossoverTriple-blindTreatment

Summary

Patients who have obstructive sleep apnea (OSA) frequently stop breathing while they sleep. They often develop high blood pressure. We are not sure what drug is best to treat the high blood pressure. This study will give the patients nebivolol or hydrochlorothiazide (HCTZ) for 6 weeks after 2 weeks of placebo. The blood pressure response will be evaluated by 24 hour monitoring.

Timeline

Start
2015-01
Primary completion
2016-04
Completion
2016-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Hydrochlorothiazide Unknown 25 mg
Subject Nebivolol Other / unclassified 10 mg